iWisdom’s Post

DELFI Diagnostics, a leader in next-generation blood-based #CancerDetection, has announced Amoolya Singh, PhD, as Chief Technology Officer. Dr. Singh will lead the strategic evolution of DELFI's AI-powered fragmentomics platform, driving unparalleled genomic insights at a game-changing cost.     "We are thrilled to welcome Dr. Singh as our Chief Technology Officer," said Susan Tousi, CEO of DELFI Diagnostics. "Her exceptional track record in developing breakthrough genomic technologies and products, combined with her deep expertise in computational biology, make her the ideal leader to advance our mission of revolutionizing cancer detection through blood-based testing. Dr. Singh's experience in building and scaling complex diagnostic platforms will be invaluable as we enter our next phase of growth and innovation."    More: https://lnkd.in/gJFKJpZF    #PartnerNews #diagnostics #genomics 

💡 Successful Virtual Mobility Grant of Marco Barreca from Università degli Studi di Milano-Bicocca ⚗ 💻 "During the Virtual Mobility period, a dedicated taskforce and I defined the main principles of dataset searching and curation. We laid the foundations for a larger project aimed at visualizing and analyzing publicly available omics datasets in the immuno-oncology field. These tools will enable researchers to easily access and organize relevant data, contributing to biomarker discovery and translational research." Congratulations Marco 👏 COST Association - European Cooperation in Science and Technology #immunomodel #virtualmobility #immunotherapy

Don’t Miss This! Dive into the future of biomedicine with us next week in #SanDiego! Join us next week at the Festival of Biologics San Diego for an interesting panel discussion brought to you by Business Location Switzerland and Swissnex in San Francisco. What’s on the Agenda?  We’re diving deep into RNA technology and its role in developing breakthrough antibody therapies to fight critical illnesses such as cancer, Alzheimer's, and autoimmune diseases. Get ready to explore the latest trends, groundbreaking research, and the challenges ahead with top experts from both #Switzerland and the #US. Meet Our Esteemed Panelists: - Rudi Micheletti, spearheading Biology and Functional Genomics at Haya Therapeutics. - Susan Szathmary, MD, PhD, leading the charge at the Open Biopharma Research and Training Institute. - Dimitrios G. Zisoulis, the mind behind RNA Therapeutics at Johnson & Johnson. - Gene Yeo, a pioneering Professor at UCSD’s Dept of Cellular and Molecular Medicine and a key figure at the UCSD Institute for Genomic Medicine. The panel discussion "Decoding the Dark Genome through RNA Technology: Ways Forward with Swiss and US Innovation’” will be moderated by the insightful Julio de Unamuno IV, Executive Director of HomeLab at UCSD. Don’t miss out on this opportunity to gain insights from leading minds in the field and discover how Swiss and US expertise is paving the way forward in biotech innovation. #biotechnology #RNAtechnology #innovation #whyswitzerland #FestivalofBiologics #healthcare #pharma

The Annual Meeting of EATRIS Bulgaria brought together top researchers and experts to discuss groundbreaking advances in translational medicine, from stem cell therapies to innovative bio-printing and 3D models. With a dedicated conference on cutting-edge research, presentations from international and Bulgarian scientists, and collaborative sessions with BBMRI-ERIC Bulgaria, the event highlighted the future of biomedical innovation. Ethical, legal, and social aspects of biobanking and new EU regulations also took centre stage. Kudos to all participants for an inspiring event driving research and collaboration forward! 👉 Find out more here: https://lnkd.in/dJCfs6aY #EATRIS_BG

It's quite common to have a packed schedule in academia, isn't it? And we get it too! That's why we've prepared a #WeeklyDigest of recent posts to help you stay in the loop and make sure you haven't missed out on anything important. 1️⃣ This week, we've unveiled groundbreaking advancements in cancer treatment. Stay tuned for updates on the progress of ten promising drugs fighting solid tumors. These drugs are pushing the boundaries of medical innovation as they make their way toward approval by the FDA and European Medicines Agency. 👉 https://lnkd.in/gWy34f2V 👈 2️⃣ Take a look back at the ACS Nano Summit hosted by City University of Hong Kong. This event is a cornerstone for the global scientific community, focusing on the latest developments in nanotechnology and its applications. Discover who attended this significant gathering. 👉 https://lnkd.in/ge8XvfSD 👈 3️⃣ Explore a revolutionary tool that combines deep learning with histopathology and methylation data. This tool offers rapid tumor classification, bypassing the need for DNA methylation profiling. With an impressive accuracy of 95%, it promises to transform neuro-oncology, enabling swift and precise diagnoses for improved patient outcomes. Curious about this game-changing breakthrough? Don't miss out! 👉 https://lnkd.in/gZ7HDPdq 👈 4️⃣ Join us in celebrating the unity of science and art! Let’s honor 7 prominent polymaths who excelled in both science and the arts. 👉 https://lnkd.in/gzvQuPs9 👈 #StayTuned #theBabakLab

🧬 A few days ago, CNAG hosted the 13th edition of the CNAG Symposium on Genome Research, an event that brought together over 200 experts to delve into the exciting world of genomics and its transformative impact on healthcare. 🔝 From groundbreaking talks by 15 leading speakers to the inspiring conversations that unfolded throughout the day, it was an unforgettable experience. 👏 We would like to extend our sincere thanks to all the speakers (Elias Campo, ANGEL ALONSO SÁNCHEZ, Elena Elez Fernández, MD PhD, Yanis Mimouni, Leslie Matalonga, Agatha Schlüter, Carmen Moreno, Pedro M Rodríguez Cruz, Angel Carracedo, Tomàs Marquès, Sukhvinder Nicklen PhD, Christophe Fleury, Yolanda Sánchez, Oscar Bolaños, Andrés Ramírez, PhD), attendees, our founders (Ministerio de Ciencia, Innovación y Universidades, Departament de Recerca i Universitats i Dpt. de Salut), and the sponsors (Illumina, Oxford Nanopore Technologies, Agilent Technologies, 10x Genomics, PacBio and Roche) for making this event possible. 📹 If you missed the event, don't worry! All the presentations are available here: https://lnkd.in/djRT9RPq Looking forward to seeing you next year! #CNAGSymposium #CNAG #Genomics #Healthcare #Cancer #RareDiseases #HealthcareInnovation #PrecisionMedicine

🚀 As we look forward to SynBioBeta 2024, we're reflecting on last year's Main Stage Panel: Revolutionizing Medicine with Synthetic Biology, an awesome discussion where we explored the boundless potential of synthetic biology in revolutionising the future of medicine! 🧬 Moderated by Meenakshi Prabhune, PhD, Editor-in-Chief at The Scientist, panellists delved into the advancements, challenges, and future directions of synthetic biology for human health. A huge shoutout to all the panellists: our CEO Mark Kotter, Kaan Certel from Sanofi, Jason Kelly from Ginkgo, Lesley Stolz from Johnson & Johnson and Professor Ron Weiss from MIT for their invaluable insights and expertise! Now, as we eagerly anticipate SynBioBeta 2024, we're thrilled to highlight part of this year's Main Stage content: "Gene Meets Cell: The SynBio Evolution in Targeted Therapeutics." 🧬 Join us for an electrifying session where we'll explore the cutting-edge realms of programmable gene and cell therapies, two of the most promising frontiers in synthetic biology. Featuring a stellar lineup of speakers including Avencia Sanchez-Mejias PhD from Integra Therapeutics, Anil Narasimha from Mekonos, Daniel Georgiev from Sampling Human and our very own Mark Kotter MD, PhD, Founder and CEO of bit.bio. Save the date: Thursday, 9th at 4:45 PM - 5:15 PM (Pacific time). Don't miss out on this unparalleled opportunity to delve into the future of medicine driven by synthetic biology! See you in San Jose! 🚀 https://hubs.ly/Q02tFPPC0 Watch Main Stage SynBioBeta 2023: https://hubs.ly/Q02tFC5z0 #SynBioBeta #SyntheticBiology #Biopharma #Medicine #GeneTherapy #CellTherapy John Cumbers

🌟 Driving Innovation in Molecular Research at Johnson & Johnson Innovative Medicine ! 🌟 I had the pleasure of representing Avantor alongside Aimy Sels from Quantabio to showcase some of the most innovative solutions driving the future of molecular biology and translational research. Together, we demonstrated how our cutting-edge technologies are accelerating breakthroughs in #PCR, real-time #qPCR, and next-generation sequencing (#NGS). 💡🔬 #Quantabio’s ultra-sensitive, high-throughput platforms—known for their precision and reproducibility—are empowering researchers to achieve exceptional detection limits, even with the most challenging samples. 🌟 These innovations are transforming research in #genomics, #oncology, and #personalized medicine, helping scientists break new ground in #discovery. 🔍🧬 #Avantor #Quantabio #PCR #qPCR #NGS #MolecularBiology #Genomics #JohnsonAndJohnson #TranslationalResearch Avantor Europe

🦙 Celebrating National Llama Day🧬 #Llamas are more than just charming, fluffy animals—they’re scientific heroes! In the late 1980s, researchers discovered that camelids (like llamas) produce unique antibodies called nanobodies. These single-domain antibodies are smaller, more stable, and highly versatile, making them a game-changer in biotechnology. From diagnostics to therapeutic development, nanobodies have opened new doors in areas like cancer treatment, infectious disease research, and structural biology. Their compact size allows them to access hard-to-reach targets, revolutionizing approaches to antibody-based solutions. So today, as we celebrate llamas, let’s honor their incredible contribution to science and human health. 🦙✨ #NationalLlamaDay #NanobodyRevolution #AntibodyResearch #Biotechnology #ScienceInnovation

I am so thankful. Yesterday, we hosted Professor Aaron Ciechanover, 2004 Nobel Laureate from the Technion - Israel Institute of Technology, and Professor Michael Halberthal, CEO of the Rambam Health Care Campus at Universidad del Desarrollo. They gave inspiring lectures at the Instituto de Ciencias e Innovación en Medicina (ICIM UDD) Facultad de Medicina Clínica Alemana Universidad del Desarrollo and shared their experiences with our PhD students from the Doctorado en Ciencias e Innovación en Medicina—many thanks to Monica Davidovich from Rambam for facilitating this activity. #genetics #genomics #precisionmedicine #genomicmedicine #nobelprize #regenerativemedicine #biotechnology #innovation #israel #chile #healthcare #startupnation #collaboration #education #drugdevelopment #drugdiscovery #aging #parkinson #cancer #neurodegeneration #research #clinicalresearch #science #sciencecommunication